期刊文献+

DEK蛋白在膀胱尿路上皮癌癌组织和尿液中的表达及临床意义 被引量:1

Expression of DEK Protein in the Tissue and Voided Urine of Patients with Bladder Urothelial Carcinoma and Its Clinical Significance
下载PDF
导出
摘要 目的探究DEK蛋白在膀胱尿路上皮癌癌组织和尿液中的表达及其与肿瘤病理分期之间的关系。方法应用免疫组化技术检测48例膀胱尿路上皮癌组织和18例癌旁正常组织DEK蛋白的表达,应用蛋白免疫印迹的方法检测28例膀胱尿路上皮癌患者和6例健康者(对照组)尿中的DEK蛋白的表达。结果膀胱尿路上皮癌癌组织中DEK蛋白的阳性表达率(73%)高于癌旁正常组织(33%,P<0.05);浅表性膀胱尿路上皮癌组织中DEK的阳性表达率(86%)高于浸润性(55%,P<0.05);膀胱尿路上皮癌患者尿液中DEK相对表达量(0.834)明显高于对照组(0.242,P<0.05);以对照组尿液中DEK的相对表达量作为标准,诊断膀胱尿路上皮癌的灵敏度可达82.1%。结论 DEK蛋白在膀胱尿路上皮癌患者癌组织和尿液中呈现阳性表达,与膀胱癌的病理分级有密切关系。癌症早期DEK蛋白在组织中的阳性表达高于癌症晚期。组织中和尿液中DEK表达认为是潜在的诊断膀胱尿路上皮癌的肿瘤标记物。 Objective To detect the presence of DEK protein in the tissue and voided urine of patients with bladder urothelial carcinoma,and analyze the relationship between DEK protein and clinical pathological classification of bladder cancer. Methods The expression of DEK protein was examined by immunohistochemistry in 48 bladder cancer tissues and 18 adjacent normal tissues(control group). The presence of DEK protein in voided urine was analyzed by western blot in 28 bladder cancer patients and 6 healthy individuals(control group). Results The positive expression of DEK protein in bladder tumor tissues(73%)is higher than in adjacent normal tissues(33%,P〈0.05). The expression of DEK in superficial bladder cancer(86%)was found higher than invasive bladder cancer(55%)with significant differences(P〈0.05). The expression of DEK in urine samples of bladder cancer patients(0.834)was found higher than control group(0.242,P〈0.05);Compared with the DEK expression of control group,the sensitivity of diagnosis of bladder cancer with voided urine could be 82.1%. Conclusion DEK protein positive expressed in tissues and voided urine of patients with bladder urothelial carcinoma. The expression was correlated with pathological classification of bladder cancer. The positive rate of DEK expression in early stage of tumor tissues is higher than late stage. The presence of DEK protein in tissues and voided urine can be considered as a suitable biomarker for bladder cancer potentially.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2016年第8期711-714,共4页 Journal of China Medical University
基金 辽宁省博士科研启动基金(20121129)
关键词 膀胱尿路上皮癌 DEK蛋白 癌组织 尿液 bladder urothelial carcinoma DEK protein cancer tissue voided urine
  • 相关文献

参考文献17

  • 1韩苏军,张思维,陈万青,李长岭.中国膀胱癌发病现状及流行趋势分析[J].癌症进展,2013,11(1):89-95. 被引量:410
  • 2JOHNSON DC, GREENE PS, NIELSEN ME. Surgical advances in bladder cancer:at what cost [J ]. Urol Clin North Am, 2015,42 (2): 235-252.
  • 3刘彩树,蔡森,张亚萍,闫合燕,李宏杰.膀胱癌尿液生物标记物的现状与展望[J].生理科学进展,2015,46(4):255-258. 被引量:4
  • 4PELLUCCHI F, FRESCHI M, IBRAHIM B, et al. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors [J]. Urology, 2011,186(6) :2194-2199.
  • 5OU Y, XIA R, LIN L, et al. Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma [I]. Oncol Lett, 2016,11 (3) : 1823-1828.
  • 6YI I-[C, UU YL, ZI-IANG ZY, et al. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma [J].Mol Med Rep ,2015,11 (2) : 1318-1323.
  • 7RIVEIRO-FALKENBACH E, SOENGAS MS. Control of tumorigne- sis and chemoresistance by the DEK oncogene [J]. Clin Cancer Res, 2010,16( 11 ) : 2932-2938.
  • 8LIU X, QI D, QI j, et al. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma [J].Oncol Rep,2016,35(1) :155-162.
  • 9华颖,胡红刚,彭向雷.DEK蛋白与细胞凋亡的研究进展[J].中国科学(C辑),2009,39(5):434-440. 被引量:8
  • 10刘光明,马洪顺.DEK蛋白和肿瘤关系的研究进展[J].中国肿瘤临床,2015,42(9):482-486. 被引量:7

二级参考文献150

共引文献442

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部